{
  "id": 5037159,
  "title": "Why Rule Breakers Buy a Stock That's Already \"Won\"",
  "url": "https://urgent.news/2026/08/31/why-rule-breakers-buy-a-stock-thats-already-won-5037159",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-31T19:57:01.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/why-rule-breakers-buy-stock-195701903.html"
  },
  "original_language": "en",
  "account": "In 2009, a little-known chipmaker called Nvidia experienced a double in value, prompting Rule Breakers to cross it off their list after waiting for a pullback that never materialized. Recently, a similar signal has appeared once again, this time for a company 1/100th the size of Nvidia. William O Neil, founder of Investors Business Daily, taught Rule Breakers co-founder David Gardner that buying high only pays if you then refuse to sell. The company Guardant Health, which went public in 2018, already had a strong run-up, gaining 96% within six weeks of its IPO. Despite falling 57% and 68% later, the stock rebounded and more than quadrupled in value, beating the market by 106 percentage points. The company's second pick, which also had a 93% run-up, also more than tripled, and UnitedHealth Group's decision to cover the test will make it accessible to around 100 million more people. While Trait #3 of Rule Breaker Investing has led to some losers, it has also proven successful in the long run.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}